Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 20.54
HDV's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. HDV: 20.54 )
Ranked among companies with meaningful P/E(ttm) only.
HDV' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 21.44
Current: 20.54
0
21.44
PE(NRI) 20.54
HDV's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. HDV: 20.54 )
Ranked among companies with meaningful PE(NRI) only.
HDV' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 21.44
Current: 20.54
0
21.44
P/B 2.97
HDV's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. HDV: 2.97 )
Ranked among companies with meaningful P/B only.
HDV' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.2
Current: 2.97
0
3.2

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.38
HDV's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. HDV: 3.38 )
Ranked among companies with meaningful Dividend Yield only.
HDV' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.54
Current: 3.38
0
3.54
Yield on cost (5-Year) 3.38
HDV's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. HDV: 3.38 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HDV' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.54
Current: 3.38
0
3.54

More Statistics

Short Percentage of Float0.00%
52-Week Range $69.26 - 83.90
Shares Outstanding (Mil)79,200,000.00
» More Articles for HDV

Headlines

Articles On GuruFocus.com
Searching for Value in the REIT Rubble Dec 09 2016 
UCB's Vimpat Patent Dec 09 2016 
The Only Rule Is It Has to Work Dec 09 2016 
David Winters' Sole Third-Quarter Pick Is Israeli Defense Company Dec 09 2016 
Abbott Laboratories Announces Quarterly Dividend Dec 09 2016 
Steven Cohen Hikes Bunge Holding by Nearly 1,500% Dec 09 2016 
A 3.5% Dividend Yield and Emerging Market Growth Dec 09 2016 
Hershey Has a Sweet Dividend, but Valuation Could Be Too Rich Dec 09 2016 
4 Gurus Invest in Hilton Worldwide Dec 09 2016 
Bill Ackman Comments on Herbalife Dec 09 2016 

More From Other Websites
Merck Is Getting Serious about Animal Health Dec 05 2016
Which Assets Find Support in a Reflationary Environment? Dec 02 2016
Ugly bond selloff isn’t stopping the dividend-ETF train Dec 01 2016
Are Dividend Growers a Better Option Than Dividend Payers? Nov 23 2016
Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016 Nov 17 2016
Pfizer’s 3Q16 Earnings: Changes in Valuations Nov 08 2016
BP Beat Estimates in 3Q16 despite Lower Earnings Nov 03 2016
Pfizer Aims to Position Avelumab as Backbone Immuno-Oncology Therapy Oct 28 2016
Where Do Institutional Holdings in HFC Stand Pre-Earnings? Oct 26 2016
Interesting Trend Developing for Pfizer’s Pneumococcal Franchise Oct 26 2016
Analysts’ Recommendations for WNR ahead of Its 3Q16 Report Oct 25 2016
Johnson & Johnson’s Profitability and Financial Guidance Oct 25 2016
What Do Analysts Say about JNJ after Its 3Q16 Results? Oct 24 2016
How Are Analysts Rating Chevron before Its 3Q16 Results? Oct 19 2016
Are Earnings Expectations for ExxonMobil Improving? Oct 18 2016
Could Johnson & Johnson’s Earnings Grow in 3Q16? Oct 17 2016
BlackRock Lowers Expenses for 15 ETFs Oct 13 2016
Looking for Inexpensive Dividend ETFs? Here They Are Oct 13 2016
Fidelity Has A Say In ETF Fee Tussle Oct 13 2016
Buy These ETFs as BlackRock Cuts Fees Oct 10 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK